HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daiji Kambe Selected Research

TS-142

7/2022Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daiji Kambe Research Topics

Disease

3Sleep Initiation and Maintenance Disorders (Insomnia)
07/2022 - 03/2015
2Sleepiness
03/2022 - 03/2015
2Schizophrenia (Dementia Praecox)
08/2015 - 02/2015
1Catalepsy
08/2015
1Cognitive Dysfunction
08/2015

Drug/Important Bio-Agent (IBA)

2Orexin Receptor AntagonistsIBA
07/2022 - 03/2015
2OrexinsIBA
01/2020 - 03/2015
2N-Methylaspartate (NMDA)IBA
08/2015 - 02/2015
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2015 - 02/2015
2Antipsychotic Agents (Antipsychotics)IBA
08/2015 - 02/2015
2Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2015 - 02/2015
1TS-142IBA
07/2022
1Orexin ReceptorsIBA
07/2022
1zopiclone (Zop)IBA
03/2022
1Glycine Plasma Membrane Transport ProteinsIBA
08/2015
1Hypnotics and Sedatives (Sedatives)IBA
03/2015
1Antidepressive Agents (Antidepressants)IBA
02/2015
1Haloperidol (Haldol)FDA LinkGeneric
02/2015
1Clozapine (Clozaril)FDA LinkGeneric
02/2015
1Serine (L-Serine)FDA Link
02/2015
1Imipramine (Janimine)FDA LinkGeneric
02/2015
1Dizocilpine Maleate (Dizocilpine)IBA
02/2015

Therapy/Procedure

1Therapeutics
03/2015